(Q34452013)

2 August 2017

1 reference

title

T-cell-directed cancer vaccines: mechanisms of immune escape and immune tolerance (English)

1 reference

evasion of host immune response

2 August 2017

main subject

1 reference

Phan GQ

1

1 reference

2 August 2017

Wang E

series ordinal

2

1 reference

2 August 2017

Marincola FM

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

Expert Opinion on Biological Therapy

2 August 2017

published in

1 reference

2 August 2017

volume

1

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

511-523

1 reference

Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Tumor antigens recognized by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Cancer vaccines based on the identification of genes encoding cancer regression antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

New paths in human cancer serology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Circulating Melan-A/Mart-1 specific cytolytic T lymphocyte precursors in HLA-A2+ melanoma patients have a memory phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Clonal deletion of thymocytes as a tumor escape mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Homeostasis and self-tolerance in the immune system: turning lymphocytes off.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Soluble HLA class I molecules: biological significance and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Tolerance, danger, and the extended family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

The binary logic of antigen processing and presentation to T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Viral immune evasion due to persistence of activated T cells without effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

The central role of CD4(+) T cells in the antitumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

CD4 T cells and their role in antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Interferon gamma (IFNgamma) gene transfer of an EMT6 tumor that is poorly responsive to IFNgamma stimulation: increase in tumor immunogenicity is accompanied by induction of a mouse class II transactivator and class II MHC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Biochemical characterization and cellular localization of a formalin-resistant melanoma-associated antigen reacting with monoclonal antibody NKI/C-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Immunophenotyping of melanomas for tyrosinase: implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Production of recombinant MART-1 proteins and specific antiMART-1 polyclonal and monoclonal antibodies: use in the characterization of the human melanoma antigen MART-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Fibrinolytic activity of ascites caused by alcoholic cirrhosis and peritoneal malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an in vitro melanoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Selection for beta 2-microglobulin mutation in mismatch repair-defective colorectal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

NK-cell receptors and recognition of MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Follow the leader: NK cell receptors for classical and nonclassical MHC class I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Natural killer cell lines kill autologous beta2-microglobulin-deficient melanoma cells: implications for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

The susceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Identification of human cancers deficient in antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Molecular characterization of defective antigen processing in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Reduction of major histocompatibility complex class I antigens on invasive and high-grade transitional cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Immunohistochemical detection of major histocompatibility complex antigens and quantitative analysis of tumour-infiltrating mononuclear cells in renal cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Involvement of MHC class I molecule and ICAM-1 in the enhancement of adhesion and cytotoxic susceptibility to immune effector cells of tumor cells transfected with the interleukin (IL)-2, IL-4 or IL-6 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Enhanced cytolytic activity of tumor infiltrating lymphocytes (TILs) derived from an ICAM-1 transfected tumor in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Tumor necrosis factor alpha (TNF alpha)-induced ICAM-1 surface expression in airway epithelial cells in vitro: possible signal transduction mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Loss of tumorigenicity and increased immunogenicity induced by interleukin-10 gene transfer in B16 melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Interleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

The Th1-Th2 hypothesis of HIV infection: new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

In situ analysis of transforming growth factor-beta s (TGF-beta 1, TGF-beta 2, TGF-beta 3), and TGF-beta type II receptor expression in malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

An innate sense of danger

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

In situ expression of transforming growth factor ?? is associated with melanoma progression and correlates with Ki67, HLA-DR and ?? 3 integrin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.511

21 January 2018

Identifiers

DOI

10.1517/14712598.1.3.511

1 reference

2 August 2017

1 reference